Literature DB >> 9095350

Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains.

S Zalipsky1, N Mullah, J A Harding, J Gittelman, L Guo, S A DeFrees.   

Abstract

Novel conjugates tailor-made for inclusion in liposomal formulations, containing distearoylphosphatidylethanolamine (DSPE) as a lipid anchor, heterobifunctional polyethylene glycol (PEG) with a molecular weight of 2000 as a linking moiety, and a biological cell adhesive ligand [YIGSR peptide or Sialyl Lewis(X) oligosaccharide (SLX)], were synthesized. They were characterized by NMR, chromatography, and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOFMS). Inclusion of either of the ligand-PEG-lipid conjugates (2 mol %) in a lecithin/cholesterol/ methoxy-PEG2000-DSPE (55:40:3 mole ratio) lipid mixture followed by preparation of unilamellar vesicles (100 nm) resulted in positioning of 55% of the YIGSR and 63% of the SLX ligands on the periphery of the outer surface-grafted polymeric "brush", as determined by a combination of specific enzymatic alterations of each ligand and HPLC. Similar densities of ligand-bearing PEG chains were incorporated into liposomes by simply incubating (37 degrees C, 5 h) either one of the ligand-PEG-lipid conjugates with preformed lipid vesicles. This conjugate insertion process was aggregation free. Using enzymatic derivatization-HPLC, it was demonstrated that all the ligands incorporated into lipid membranes by this new approach were positioned exclusively on the outer leaflet of the liposomal bilayers. Since liposomes of this type are intended for in vivo use as long-circulating, ligand-presenting platforms, the insertion approach is preferable because of the more efficient utilization of ligand-PEG-lipid conjugates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9095350     DOI: 10.1021/bc9600832

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  6 in total

1.  Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity.

Authors:  João N Moreira; Tatsuhiro Ishida; Rogério Gaspar; Theresa M Allen
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

2.  In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles.

Authors:  Xingfang Su; Jennifer Fricke; Daniel G Kavanagh; Darrell J Irvine
Journal:  Mol Pharm       Date:  2011-04-01       Impact factor: 4.939

3.  Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy.

Authors:  Han-Chung Wu; De-Kuan Chang
Journal:  J Oncol       Date:  2010-05-05       Impact factor: 4.375

Review 4.  The baffling human body and the boundless nanomaterial boon-a trap for cancer crab.

Authors:  S Jeelani; G S Asokan; G Anuradha; J Parthiban; T Sivasankari
Journal:  J Clin Diagn Res       Date:  2014-07-20

Review 5.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

6.  Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands.

Authors:  Oula Penate Medina; Merja Haikola; Marja Tahtinen; Ilkka Simpura; Sami Kaukinen; Heli Valtanen; Ying Zhu; Sari Kuosmanen; Wei Cao; Justus Reunanen; Tuula Nurminen; Per E J Saris; Peter Smith-Jones; Michelle Bradbury; Steven Larson; Kalevi Kairemo
Journal:  J Drug Deliv       Date:  2010-12-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.